Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib improved multiple immune-related conditions in one patient.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Tofacitinib taken by mouth helps treat hair loss in children.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Combining paroxetine and triamcinolone effectively treats both alopecia areata and depression.

Tofacitinib might be used to treat hair loss.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Metyrapone effectively stabilizes severe Cushing's disease symptoms before surgery.

Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Activated ras can protect kidney cells from a certain substance that causes cell death.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

GLP-1 receptor agonists help women with PCOS lose weight and improve health, but more research is needed on long-term effects.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Ritlecitinib and brepocitinib effectively regrow hair in alopecia areata patients.

Tislelizumab can cause cutaneous lupus erythematosus.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.